Pasithea Therapeutics Opens its First Ketamine Therapy Clinic in the United Kingdom

by divibasicbldev | Oct 14, 2021 | Press Releases

— Pasithea Clinics partners with ZEN Healthcare – a network of health clinics in Central London – to offer ketamine infusion therapy for the treatment of mental health disorders — — Ketamine in sub-anesthetic doses has shown to be highly...

Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement

by divibasicbldev | Oct 11, 2021 | Press Releases

— Company contracts leading global drug development company to advance initial drug candidate –MIAMI BEACH, Fla., Oct. 11, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a...

Pasithea Therapeutics Corp. to Present at the Benzinga Healthcare Small Cap Conference

by divibasicbldev | Sep 29, 2021 | Press Releases

MIAMI BEACH, Fla., Sept. 29, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric...

Pasithea Therapeutics Corp. Announces Closing of $24.0 Million Initial Public Offering

by divibasicbldev | Sep 17, 2021 | Press Releases

MIAMI BEACH, Fla., Sept. 17, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric...

Pasithea Therapeutics Corp. Announces Pricing of Upsized $24.0 Million Initial Public Offering

by divibasicbldev | Sep 15, 2021 | Press Releases

MIAMI BEACH, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological...